SEC Form 4 · accession 0001209191-17-054665
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antonio R Pera
Officer — President, Par Pharmaceutical
Period of report
Oct 1, 2017
Accepted (ET)
Oct 2, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Oct 1, 2017 | F | 135 | $8.48 | D | 19,570 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Mr. Pera's October 1, 2015 grant of restricted stock units (RSUs) vested on October 1, 2017.
- F2These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs.
- F3Represents the vesting price which is the average of the high and low share price on September 29, 2017, the last trading day prior to vesting.